Author:
Li Qiong,Zhang Daoxiang,Chen Xiaoying,He Lei,Li Tianming,Xu Xiaoping,Li Min
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Jemal, A. et al. Global cancer statistics. CA Cancer J Clin. 61, 69–90 (2011).
2. Wheeler, D. L., Dunn, E. F. & Harari, P. M. Understanding resistance to EGFR inhibitors-impact on future treatment strategies. Nat Rev Clin Oncol. 7, 493–507 (2010).
3. Prahallad, A. et al. Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. Nature. 483, 100–103 (2012).
4. Lou, Y. F. et al. Combination of gefitinib and DNA methylation inhibitor decitabine exerts synergistic anti-cancer activity in colon cancer cells. Plos One. 9, e97719 (2014).
5. Kijima, T. et al. STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo. Cell Growth Diffe. 13, 355–362 (2002).
Cited by
89 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献